1009-17-2

Basic information

• Product Name: N-(2-aminoethyl)benzamide
• Synonyms: N-(2-aminoethyl)benzamide;N-Benzoylethylenediamine
• CAS NO: 1009-17-2
• Molecular Formula: C₉H₁₂N₂O
• Molecular Weight: 164.20438
• Mol File: 1009-17-2.mol
• Article Data: 37

Chemical Properties

• Appearance: /
• Storage Temp.: Refrigerator, under inert atmosphere
• Solubility: Chloroform (Slightly), Methanol (Slightly)
• CAS DataBase Reference: N-(2-aminoethyl)benzamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(2-aminoethyl)benzamide(1009-17-2)
• EPA Substance Registry System: N-(2-aminoethyl)benzamide(1009-17-2)

Safety Data

• Hazardous Substances Data: 1009-17-2(Hazardous Substances Data)

Usage

Description

N-(2-aminoethyl)benzamide, also known as benzoyl ethylenediamine, is a chemical compound with the molecular formula C9H12N2O. It is a derivative of benzamide and ethylenediamine, combining a benzene ring with an aminoethyl group. N-(2-aminoethyl)benzamide is commonly used in organic synthesis and pharmaceutical research, acting as a building block for various compounds and medications.

Uses

Used in Organic Synthesis:
N-(2-aminoethyl)benzamide is used as a building block for the synthesis of various organic compounds. Its unique structure allows it to be a versatile component in the creation of new molecules with potential applications in various industries.
Used in Pharmaceutical Research:
In the pharmaceutical industry, N-(2-aminoethyl)benzamide is used as a starting material for the development of new medications. Its ability to interact with proteins and enzymes in the body makes it a promising candidate for the treatment of various medical conditions.
Used in Cancer Treatment Research:
N-(2-aminoethyl)benzamide has been studied for its potential as a treatment for various types of cancer. Its interactions with proteins and enzymes in the body suggest that it may have therapeutic effects against cancer cells, warranting further research into its efficacy and safety.
Used in Neurological Disorder Research:
Due to its interactions with proteins and enzymes, N-(2-aminoethyl)benzamide is also being investigated for its potential to treat neurological disorders. N-(2-aminoethyl)benzamide's ability to modulate biological processes in the nervous system could lead to new treatments for conditions such as Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders.
Further research is needed to fully understand the potential applications and effects of N-(2-aminoethyl)benzamide, as its diverse uses and interactions with biological systems hold promise for future advancements in medicine and other fields.

Upstream product

• 93-97-0 benzoic acid anhydride 
• 107-15-3 ethylenediamine 
• 23405-15-4 benzoic acid N-hydroxysuccinimide ester 
• 10364-94-0 1-benzoylimidazole 
• 333-18-6 1,2-diaminoethane dihydrochloride 
• 65-85-0 benzoic acid 
• 57260-73-8 N-BOC-1,2-diaminoethane 
• 98-88-4 benzoyl chloride 
• 4231-62-3 1-benzoyl-1H-benzotriazole 
• 37593-94-5 4-chloro-2-nitrophenyl benzoate 
• 1021188-73-7 tert-butyl (2-benzamidoethyl)carbamate 
• 72200-26-1 N-(2-azido-ethyl)-benzamide 
• 7127-19-7 2-phenyl-1,3-oxazoline 
• 120-51-4 benzoic acid benzyl ester 

Downstream Products

• 67630-76-6 N-benzyl-N'-benzoylethylenediamine 
• 1446714-11-9 N-[2-(tritylamino)ethyl]benzamide 
• 1379000-37-9 C₁₉H₂₇N₃O₃ 
• 1261242-27-6 N-(2-((4-(6-(4-fluorophenyl)imidazo[2,1-b]thiazol-5-yl)pyrimidin-2-yl)amino)ethyl)benzamide 
• 1350454-80-6 N-(2-(4-(6-(3-methoxyphenyl)imidazo[2,1-b]thiazol-5-yl)pyrimidin-2-ylamino)ethyl)benzamide 
• 1190955-41-9 C₁₉H₁₆FN₃O₃ 

Relevant articles and documents

Electrochemical: N-acylation synthesis of amides under aqueous conditions

An electrochemical N-acylation of carboxylic acids with amines was reported. The sustainable TBAB electrocatalysis proceeded with excellent chemoselectivity and positional selectivity, and with ample scope, allowing electrochemical N-acylation under mild reaction conditions at room temperature in water. Moreover, the synthetic utility of the current method is demonstrated by the synthesis of melatonin.

N-benzoate-N' salicylaldehyde ethynelediamine: A new fluorescent sensor for Zn2+ ion by "off-on" mode

Imbalance of zinc ion (Zn2+) in human body causes diseases like Alzheimer's and Parkinson's and therefore Zn2+ estimation in biological fluids has diagnostic values. Fluorescence "off-on" sensors have advantages of high sensitivity a

-

-

Imidazothiazole-based potent inhibitors of V600E-B-RAF kinase with promising anti-melanoma activity: biological and computational studies

A series of imidazothiazole derivatives possessing potential activity against melanoma cells were investigated for molecular mechanism of action. The target compounds were tested against V600E-B-RAF and RAF1 kinases. Compound 1zb is the most potent agains

Method for preparing derivatives of benzamide under microwave condition in aqueous phase

The invention discloses a method for preparing derivatives of benzamide under a microwave condition in an aqueous phase. A coupling reaction is carried out between substituted benzoic acid and amine under the microwave condition in the aqueous phase. The method for preparing the derivatives of benzamide is environmentally friendly, easy and convenient to operate, safe, low in cost and efficient. Compared with the prior art, the method can be applicable to a large number of functional groups, is high in yield, produces fewer by-products, and further is easy to operate, safe, low in cost and environmentally friendly. A formula is shown in the description.